San Diego, January 23, 2026
Biocom has unveiled an esteemed keynote panel for its upcoming Global Partnering & Investor Conference, featuring leaders from Amgen, AbbVie, and Eli Lilly. This event, taking place at The Lodge at Torrey Pines, will discuss pivotal topics in drug discovery and AI’s role in drug development, offering unique insights into industry collaboration. The conference aims to facilitate networking among over 500 investors and executives in the pharmaceutical and biotech sectors, fostering valuable connections and discussions about emerging trends.
San Diego, California – Biocom Announces Keynote Panel for 2026 Global Partnering & Investor Conference
San Diego, California – Biocom has announced a distinguished keynote session for its 2026 Global Partnering & Investor Conference, scheduled for February 24 to 26 at The Lodge at Torrey Pines in La Jolla, California. The session will feature leaders from three major pharmaceutical companies: Amgen, AbbVie, and Eli Lilly.
Keynote Panel Details
The keynote panel will include:
- Jay Bradner, M.D., Executive Vice President of Research and Development at Amgen
- Jonathon Sedgwick, Ph.D., Senior Vice President and Global Head of Discovery Research at AbbVie
- Daniel Skovronsky, M.D., Ph.D., Chief Scientific and Product Officer and President of Lilly Research Laboratories at Eli Lilly
The session will be moderated by Steven Paul, M.D., Board Chair of the Foundation for the National Institutes of Health, Venture Partner at Third Rock Ventures, and former President of Lilly Research Laboratories. This unscripted discussion will cover topics such as innovation in drug discovery, the role of AI in accelerating drug development, and effective collaboration between biotech and large pharmaceutical companies.
Conference Overview
Biocom’s Global Partnering & Investor Conference brings together over 500 investors and senior executives from leading pharmaceutical, biotech, and research organizations worldwide. The conference features panel discussions, one-on-one partnering meetings, presentations from emerging companies, and extensive networking opportunities. For more information and registration details, visit Biocom’s official conference page.
About Biocom
For over 30 years, Biocom has advanced the life science industry by providing resources that accelerate innovation. The organization offers access to funding and partnering opportunities, group purchasing solutions, policy and advocacy support, and workforce development programs to strengthen talent pipelines.
Recent Developments in the Pharmaceutical Industry
In related news, Takeda Pharmaceuticals, a major player in the pharmaceutical industry, has announced a strategic shift resulting in the layoff of 137 employees at its Massachusetts R&D site. This decision is part of a broader realignment of the company’s research and development focus. Affected employees will receive severance packages and 60-day notices. Despite these changes, Takeda remains Massachusetts’ largest life sciences employer, with over 5,800 employees in the state. The company continues to invest in areas such as oncology, rare diseases, neuroscience, and gastroenterology.
Stock Market Updates
As of January 23, 2026, the stock performances of the companies involved in the upcoming Biocom conference are as follows:
| Company | Stock Price (USD) | Change (%) | Intraday High (USD) | Intraday Low (USD) | Volume |
|---|---|---|---|---|---|
| Amgen Inc. (AMGN) | 347.07 | +0.99% | 349.97 | 342.19 | 3,025,150 |
| AbbVie Inc. (ABBV) | 218.11 | +0.87% | 219.04 | 214.81 | 5,650,881 |
| Eli Lilly & Co. (LLY) | 1,087.38 | +0.82% | 1,095.15 | 1,072.46 | 2,478,217 |
| Takeda Pharmaceutical Co. (TAK) | 15.94 | -0.87% | 16.04 | 15.87 | 3,862,551 |
Conclusion
The upcoming Biocom Global Partnering & Investor Conference promises to be a significant event, offering valuable insights from leaders in the pharmaceutical industry. Attendees can look forward to discussions on cutting-edge developments in drug discovery and development, as well as opportunities for networking and collaboration.
FAQ
What is the Biocom Global Partnering & Investor Conference?
The Biocom Global Partnering & Investor Conference is an annual event that brings together investors and senior executives from leading pharmaceutical, biotech, and research organizations worldwide. The conference features panel discussions, one-on-one partnering meetings, presentations from emerging companies, and extensive networking opportunities.
When and where is the 2026 conference taking place?
The 2026 conference is scheduled for February 24 to 26 at The Lodge at Torrey Pines in La Jolla, California.
Who are the keynote speakers for the 2026 conference?
The keynote panel will include Jay Bradner, M.D., Executive Vice President of Research and Development at Amgen; Jonathon Sedgwick, Ph.D., Senior Vice President and Global Head of Discovery Research at AbbVie; and Daniel Skovronsky, M.D., Ph.D., Chief Scientific and Product Officer and President of Lilly Research Laboratories at Eli Lilly. The session will be moderated by Steven Paul, M.D., Board Chair of the Foundation for the National Institutes of Health, Venture Partner at Third Rock Ventures, and former President of Lilly Research Laboratories.
What topics will be discussed during the keynote session?
The unscripted discussion will cover topics such as innovation in drug discovery, the role of AI in accelerating drug development, and effective collaboration between biotech and large pharmaceutical companies.
How can I register for the conference?
For more information and registration details, visit Biocom’s official conference page.
What recent developments have occurred in the pharmaceutical industry?
Recently, Takeda Pharmaceuticals announced a strategic shift resulting in the layoff of 137 employees at its Massachusetts R&D site. This decision is part of a broader realignment of the company’s research and development focus. Affected employees will receive severance packages and 60-day notices. Despite these changes, Takeda remains Massachusetts’ largest life sciences employer, with over 5,800 employees in the state. The company continues to invest in areas such as oncology, rare diseases, neuroscience, and gastroenterology.
Deeper Dive: News & Info About This Topic
HERE Resources
NVIDIA Unveils DGX Spark and DGX Station AI Supercomputers
Author: STAFF HERE SAN DIEGO WRITER
The SAN DIEGO STAFF WRITER represents the experienced team at HERESanDiego.com, your go-to source for actionable local news and information in San Diego, San Diego County, and beyond. Specializing in "news you can use," we cover essential topics like product reviews for personal and business needs, local business directories, politics, real estate trends, neighborhood insights, and state news affecting the area—with deep expertise drawn from years of dedicated reporting and strong community input, including local press releases and business updates. We deliver top reporting on high-value events such as Comic-Con International, San Diego County Fair, and San Diego Pride Festival. Our coverage extends to key organizations like the San Diego Regional Chamber of Commerce and United Way of San Diego County, plus leading businesses in biotechnology, healthcare, and technology that power the local economy such as Qualcomm, Illumina, and Scripps Health. As part of the broader HERE network, including HEREAnaheim.com, HEREBeverlyHills.com, HERECostaMesa.com, HERECoronado.com, HEREHollywood.com, HEREHuntingtonBeach.com, HERELongBeach.com, HERELosAngeles.com, HEREMissionViejo.com, and HERESantaAna.com, we provide comprehensive, credible insights into California's dynamic landscape.
